Header Logo

Connection

NANCY DUGAL PERRIER to Retrospective Studies

Back to Details
This is a "connection" page, showing publications NANCY DUGAL PERRIER has written about Retrospective Studies.
NANCY DUGAL PERRIER
Connection Strength
1.490
Retrospective Studies
  1. Beyond the three P's: adrenal involvement in MEN1. Endocr Relat Cancer. 2024 Feb 01; 31(2).
    View in: PubMed
    Score: 0.049
  2. Management of adrenocorticotropic hormone-secreting neuroendocrine tumors and the role of bilateral adrenalectomy in ectopic Cushing syndrome. Surgery. 2022 08; 172(2):559-566.
    View in: PubMed
    Score: 0.043
  3. Evaluation of risk factors, long-term outcomes, and immediate and delayed autotransplantation to minimize postsurgical hypoparathyroidism in multiple endocrine neoplasia type 1 (MEN1): A retrospective cohort study. Surgery. 2022 05; 171(5):1240-1246.
    View in: PubMed
    Score: 0.042
  4. Understanding the clinical course of genotype-negative MEN1 patients can inform management strategies. Surgery. 2021 01; 169(1):175-184.
    View in: PubMed
    Score: 0.038
  5. Understanding Thyroidectomy Cost Variations Among National Cancer Institute-Designated Cancer Centers. World J Surg. 2020 02; 44(2):385-392.
    View in: PubMed
    Score: 0.037
  6. Risks of Hypoparathyroidism After Total Thyroidectomy in Children: A 21-Year Experience in a High-Volume Cancer Center. World J Surg. 2020 Feb; 44(2):442-451.
    View in: PubMed
    Score: 0.037
  7. Diagnostic performance of adrenal CT in the differentiation of adenoma and pheochromocytoma. Acta Radiol. 2020 Aug; 61(8):1080-1086.
    View in: PubMed
    Score: 0.037
  8. Risk of Distant Metastasis in Parathyroid Carcinoma and Its Effect on Survival: A Retrospective Review from a High-Volume Center. Ann Surg Oncol. 2019 Oct; 26(11):3593-3599.
    View in: PubMed
    Score: 0.035
  9. Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death-ligand 1 expression and the presence of tumor-infiltrating lymphocytes and macrophages. Surgery. 2018 11; 164(5):960-964.
    View in: PubMed
    Score: 0.033
  10. The diagnostic accuracy of neck ultrasound, 4D-Computed tomographyand sestamibi imaging in parathyroid carcinoma. Eur J Radiol. 2017 Oct; 95:82-88.
    View in: PubMed
    Score: 0.031
  11. Considering Postoperative Functional Hypoaldosteronism after Unilateral Adrenalectomy. Am Surg. 2017 Jun 01; 83(6):598-604.
    View in: PubMed
    Score: 0.031
  12. Is estrogen exposure a protective factor for pancreatic neuroendocrine tumours in female patients with multiple endocrine neoplasia syndrome type 1? Clin Endocrinol (Oxf). 2017 Jun; 86(6):791-797.
    View in: PubMed
    Score: 0.031
  13. Operative intervention for primary hyperparathyroidism offers greater bone recovery in patients with sporadic disease than in those with multiple endocrine neoplasia type 1-related hyperparathyroidism. Surgery. 2017 01; 161(1):107-115.
    View in: PubMed
    Score: 0.030
  14. Oncologic progress for the treatment of parathyroid carcinoma is needed. J Surg Oncol. 2016 Nov; 114(6):708-713.
    View in: PubMed
    Score: 0.030
  15. Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients. Clin Endocrinol (Oxf). 2016 09; 85(3):400-7.
    View in: PubMed
    Score: 0.029
  16. Clinical Features, Treatments, and Outcomes of Patients with Thymic Carcinoids and Multiple Endocrine Neoplasia Type 1 Syndrome at MD Anderson Cancer Center. Horm Cancer. 2016 08; 7(4):279-87.
    View in: PubMed
    Score: 0.029
  17. Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; A clinico-pathologic challenge. The MD Anderson case series and review of the literature. Int J Surg. 2016 Jul; 31:10-6.
    View in: PubMed
    Score: 0.029
  18. Differentiating Atypical Parathyroid Neoplasm from Parathyroid Cancer. Ann Surg Oncol. 2016 09; 23(9):2889-97.
    View in: PubMed
    Score: 0.029
  19. Cervical hematoma following an endocrine surgical procedure: The MD Anderson experience. Surgery. 2016 08; 160(2):377-83.
    View in: PubMed
    Score: 0.028
  20. Fewer adverse events after reoperative parathyroidectomy associated with initial minimally invasive parathyroidectomy. Am J Surg. 2014 Nov; 208(5):850-855.
    View in: PubMed
    Score: 0.025
  21. Adrenal metastectomy is safe in selected patients. World J Surg. 2014 Jun; 38(6):1336-42.
    View in: PubMed
    Score: 0.025
  22. Impact of surgical resection for subdiaphragmatic paragangliomas. World J Surg. 2014 Mar; 38(3):733-41.
    View in: PubMed
    Score: 0.025
  23. Preoperative multiple endocrine neoplasia type 1 diagnosis improves the surgical outcomes of pediatric patients with primary hyperparathyroidism. J Pediatr Surg. 2014 Apr; 49(4):546-50.
    View in: PubMed
    Score: 0.024
  24. Pre-operative ultrasound identification of thyroiditis helps predict the need for thyroid hormone replacement after thyroid lobectomy. Endocr Pract. 2013 Nov-Dec; 19(6):1015-20.
    View in: PubMed
    Score: 0.024
  25. The role of thyroidectomy in metastatic disease to the thyroid gland. Ann Surg Oncol. 2014 Feb; 21(2):434-9.
    View in: PubMed
    Score: 0.024
  26. Long-term outcomes of surgical treatment for hereditary pheochromocytoma. J Am Coll Surg. 2013 Feb; 216(2):280-9.
    View in: PubMed
    Score: 0.023
  27. Preoperative serum osteocalcin may predict postoperative elevated parathyroid hormone in patients with primary hyperparathyroidism. World J Surg. 2012 Jun; 36(6):1320-6.
    View in: PubMed
    Score: 0.022
  28. Predictable criteria for selective, rather than routine, calcium supplementation following thyroidectomy. Arch Surg. 2012 Apr; 147(4):338-44.
    View in: PubMed
    Score: 0.021
  29. Robot-assisted transaxillary thyroid surgery in the United States: is it comparable to open thyroid lobectomy? Ann Surg Oncol. 2012 Apr; 19(4):1269-74.
    View in: PubMed
    Score: 0.021
  30. Posterior retroperitoneoscopic adrenalectomy is a safe and effective alternative to transabdominal laparoscopic adrenalectomy for pheochromocytoma. Surgery. 2011 Sep; 150(3):452-8.
    View in: PubMed
    Score: 0.021
  31. Posterior retroperitoneoscopic adrenalectomy: a contemporary American experience. J Am Coll Surg. 2011 Apr; 212(4):659-65; discussion 665-7.
    View in: PubMed
    Score: 0.020
  32. Common locations of parathyroid adenomas. Ann Surg Oncol. 2011 Apr; 18(4):1047-51.
    View in: PubMed
    Score: 0.020
  33. Reoperative parathyroidectomy: location of missed glands based on a contemporary nomenclature system. Arch Surg. 2010 Nov; 145(11):1065-8.
    View in: PubMed
    Score: 0.020
  34. Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy. Ann Surg Oncol. 2009 Nov; 16(11):3146-53.
    View in: PubMed
    Score: 0.018
  35. The fallen one: the inferior parathyroid gland that descends into the mediastinum. J Am Coll Surg. 2009 May; 208(5):887-93; discussion 893-5.
    View in: PubMed
    Score: 0.018
  36. Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial? Surgery. 2008 Dec; 144(6):852-8; discussion 858-9.
    View in: PubMed
    Score: 0.017
  37. Impact of preoperative thyroid ultrasonography on the surgical management of primary hyperparathyroidism. Br J Surg. 2008 Aug; 95(8):957-60.
    View in: PubMed
    Score: 0.017
  38. Abdominal visceral lesions in von Hippel-Lindau disease: incidence and clinical behavior of pancreatic and adrenal lesions at a single center. World J Surg. 2006 May; 30(5):665-9.
    View in: PubMed
    Score: 0.014
  39. Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. World J Surg. 2006 May; 30(5):643-53.
    View in: PubMed
    Score: 0.014
  40. Vacuum-assisted closure for the treatment of complex breast wounds. Breast. 2006 Oct; 15(5):610-3.
    View in: PubMed
    Score: 0.014
  41. Is parathyroid carcinoma indeed a lethal disease? Ann Surg Oncol. 2005 Mar; 12(3):260-6.
    View in: PubMed
    Score: 0.013
  42. Is there a racial difference in presentation of primary hyperparathyroidism? Am Surg. 2004 Jun; 70(6):504-6.
    View in: PubMed
    Score: 0.013
  43. Postoperative Global Period Cost Reduction Using 3 Successive Risk-Stratified Pancreatectomy Clinical Pathways. J Am Coll Surg. 2024 Apr 01; 238(4):451-459.
    View in: PubMed
    Score: 0.012
  44. HER2 expression in thyroid tumors. Am Surg. 2003 Dec; 69(12):1100-3.
    View in: PubMed
    Score: 0.012
  45. Decreasing utilization for postoperative radiation therapy in locoregionally advanced medullary thyroid cancer. Head Neck. 2024 Feb; 46(2):328-335.
    View in: PubMed
    Score: 0.012
  46. Incidence and Geographical Distribution of Adrenocortical Carcinoma: Retrospective Analysis of a State Cancer Registry. Endocr Pract. 2024 Jan; 30(1):25-30.
    View in: PubMed
    Score: 0.012
  47. Experienced scintigraphers contribute to success of minimally invasive parathyroidectomy by skilled endocrine surgeons. Am Surg. 2003 Jun; 69(6):478-83; discussion 483-4.
    View in: PubMed
    Score: 0.012
  48. TNM Staging and Overall Survival in Patients With Pheochromocytoma and Sympathetic Paraganglioma. J Clin Endocrinol Metab. 2023 04 13; 108(5):1132-1142.
    View in: PubMed
    Score: 0.012
  49. Temporal Trends in Outcomes in Patients With Adrenocortical Carcinoma: A Multidisciplinary Referral-center Experience. J Clin Endocrinol Metab. 2022 04 19; 107(5):1239-1246.
    View in: PubMed
    Score: 0.011
  50. A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression. J Clin Endocrinol Metab. 2021 11 19; 106(12):e4969-e4980.
    View in: PubMed
    Score: 0.011
  51. Recurrence after successful parathyroidectomy-Who should we worry about? Surgery. 2022 01; 171(1):40-46.
    View in: PubMed
    Score: 0.010
  52. Death related to propofol use in an adult patient. Crit Care Med. 2000 Aug; 28(8):3071-4.
    View in: PubMed
    Score: 0.010
  53. Radiomic mapping model for prediction of Ki-67 expression in adrenocortical carcinoma. Clin Radiol. 2020 06; 75(6):479.e17-479.e22.
    View in: PubMed
    Score: 0.009
  54. Post-thyroidectomy emergency room visits and readmissions: Assessment from the Collaborative Endocrine Surgery Quality Improvement Program (CESQIP). Am J Surg. 2020 10; 220(4):813-820.
    View in: PubMed
    Score: 0.009
  55. Using a Novel Diagnostic Nomogram to Differentiate Malignant from Benign Parathyroid Neoplasms. Endocr Pathol. 2019 Dec; 30(4):285-296.
    View in: PubMed
    Score: 0.009
  56. Novel use of a Clinical Laboratory Improvements Amendments (CLIA)-certified Cyclin-Dependent Kinase N2C (CDKN2C) loss assay in?sporadic medullary thyroid carcinoma. Surgery. 2020 01; 167(1):80-86.
    View in: PubMed
    Score: 0.009
  57. Solitary Parathyroid Adenoma Localization in Technetium Tc99m Sestamibi SPECT and Multiphase Multidetector 4D CT. AJNR Am J Neuroradiol. 2019 01; 40(1):142-149.
    View in: PubMed
    Score: 0.009
  58. High prevalence of chronic kidney disease in patients with multiple endocrine neoplasia type 1 and improved kidney function after parathyroidectomy. Surgery. 2019 01; 165(1):124-128.
    View in: PubMed
    Score: 0.009
  59. Operation duration and adrenal gland size, but not BMI, are correlated with complication rate for posterior retroperitoneoscopic adrenalectomy for benign diseases. Surgery. 2019 03; 165(3):637-643.
    View in: PubMed
    Score: 0.008
  60. Tumor Size and Presence of Metastatic Disease at Diagnosis are Associated with Disease-Specific Survival in Parathyroid Carcinoma. Ann Surg Oncol. 2018 Sep; 25(9):2535-2540.
    View in: PubMed
    Score: 0.008
  61. Thyroid cancer in patients with familial adenomatous polyposis. World J Surg. 1998 Jul; 22(7):738-42; discussion 743.
    View in: PubMed
    Score: 0.008
  62. Impact of Surgical Resection of the Primary Tumor on Overall Survival in Patients With Metastatic Pheochromocytoma or Sympathetic Paraganglioma. Ann Surg. 2018 07; 268(1):172-178.
    View in: PubMed
    Score: 0.008
  63. Utility of Intermediate-Delay Washout CT Images for Differentiation of Malignant and Benign Adrenal Lesions: A Multivariate Analysis. AJR Am J Roentgenol. 2018 08; 211(2):W109-W115.
    View in: PubMed
    Score: 0.008
  64. Genotype-phenotype pancreatic neuroendocrine tumor relationship in multiple endocrine neoplasia type 1 patients: A 23-year experience at a single institution. Surgery. 2018 01; 163(1):212-217.
    View in: PubMed
    Score: 0.008
  65. Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness. J Clin Endocrinol Metab. 2017 08 01; 102(8):2807-2813.
    View in: PubMed
    Score: 0.008
  66. Postoperative local-regional radiation therapy in the treatment of parathyroid carcinoma: The MD Anderson experience of 35 years. Pract Radiat Oncol. 2017 Nov - Dec; 7(6):e463-e470.
    View in: PubMed
    Score: 0.008
  67. All in the family? Analyzing the impact of family history in addition to genotype on medullary thyroid carcinoma aggressiveness in MEN2A patients. Fam Cancer. 2017 04; 16(2):283-289.
    View in: PubMed
    Score: 0.008
  68. Diagnostic performance of 18-F-FDG-PET-CT in adrenal lesions using histopathology as reference standard. Abdom Radiol (NY). 2017 02; 42(2):577-584.
    View in: PubMed
    Score: 0.008
  69. An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer. Thyroid. 2016 Mar; 26(3):373-80.
    View in: PubMed
    Score: 0.007
  70. An immunohistochemical survey for neuroendocrine cells in regional pancreatic lymph nodes: a plausible explanation for primary nodal gastrinomas? Mayo Clinic Pancreatic Surgery Group. Surgery. 1995 Dec; 118(6):957-65; discussion 965-6.
    View in: PubMed
    Score: 0.007
  71. Parathyroid Carcinoma: An Update on Treatment Outcomes and Prognostic Factors from the National Cancer Data Base (NCDB). Ann Surg Oncol. 2015 Nov; 22(12):3990-5.
    View in: PubMed
    Score: 0.007
  72. Surgical resection of synchronously metastatic adrenocortical cancer. Ann Surg Oncol. 2015 Jan; 22(1):146-51.
    View in: PubMed
    Score: 0.006
  73. Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy. World J Surg. 2014 Jun; 38(6):1318-27.
    View in: PubMed
    Score: 0.006
  74. Progress in the operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg. 2004 May; 239(5):704-8; discussion 708-11.
    View in: PubMed
    Score: 0.006
  75. Impact and timing of bilateral adrenalectomy for refractory adrenocorticotropic hormone-dependent Cushing?s syndrome. Surgery. 2013 Dec; 154(6):1174-83; discussion 1183-4.
    View in: PubMed
    Score: 0.006
  76. Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma? Surgery. 2003 Dec; 134(6):918-22; discussion 922-3.
    View in: PubMed
    Score: 0.006
  77. The biopsy-proven benign thyroid nodule: is long-term follow-up necessary? J Am Coll Surg. 2013 Jul; 217(1):81-8; discussion 88-9.
    View in: PubMed
    Score: 0.006
  78. A retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma. J Clin Endocrinol Metab. 2013 Jan; 98(1):192-7.
    View in: PubMed
    Score: 0.006
  79. Ultrasonography should not guide the timing of thyroidectomy in pediatric patients diagnosed with multiple endocrine neoplasia syndrome 2A through genetic screening. Ann Surg Oncol. 2013 Jan; 20(1):53-9.
    View in: PubMed
    Score: 0.006
  80. Accuracy of four-dimensional CT for the localization of abnormal parathyroid glands in patients with primary hyperparathyroidism. Radiology. 2012 Sep; 264(3):789-95.
    View in: PubMed
    Score: 0.005
  81. Liver resection for liver metastases from nondigestive endocrine cancer: extrahepatic disease burden defines outcome. Surgery. 2012 Jun; 151(6):851-9.
    View in: PubMed
    Score: 0.005
  82. Achieving eugastrinemia in MEN1 patients: both duodenal inspection and formal lymph node dissection are important. Surgery. 2011 Dec; 150(6):1143-52.
    View in: PubMed
    Score: 0.005
  83. Imaging characteristics of hyperfunctioning parathyroid adenomas using multiphase multidectector computed tomography: a quantitative and qualitative approach. J Comput Assist Tomogr. 2011 Sep-Oct; 35(5):560-7.
    View in: PubMed
    Score: 0.005
  84. CT features and quantification of the characteristics of adrenocortical carcinomas on unenhanced and contrast-enhanced studies. Clin Radiol. 2012 Jan; 67(1):38-46.
    View in: PubMed
    Score: 0.005
  85. Cystic lymph nodes in the lateral neck as indicators of metastatic papillary thyroid cancer. Endocr Pract. 2011 Mar-Apr; 17(2):240-4.
    View in: PubMed
    Score: 0.005
  86. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. J Clin Endocrinol Metab. 2011 Mar; 96(3):717-25.
    View in: PubMed
    Score: 0.005
  87. Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane. Ann Surg Oncol. 2010 Jan; 17(1):263-70.
    View in: PubMed
    Score: 0.005
  88. Failure to recognize multiple endocrine neoplasia 2B: more common than we think? Ann Surg Oncol. 2008 Jan; 15(1):293-301.
    View in: PubMed
    Score: 0.004
  89. Carcinoid tumors of the duodenum. Surgery. 2005 Dec; 138(6):971-7; discussion 977-8.
    View in: PubMed
    Score: 0.003
  90. Laparoscopic resection of adrenal cortical carcinoma: a cautionary note. Surgery. 2005 Dec; 138(6):1078-85; discussion 1085-6.
    View in: PubMed
    Score: 0.003
  91. Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Arch Surg. 2005 Apr; 140(4):374-82.
    View in: PubMed
    Score: 0.003
  92. Providing optimal preoperative localization for recurrent parathyroid carcinoma: a combined parathyroid scintigraphy and computed tomography approach. Clin Nucl Med. 2004 Nov; 29(11):681-4.
    View in: PubMed
    Score: 0.003
  93. Complication of thyroidectomy in patients with radiation-induced thyroid neoplasms. Arch Surg. 2004 Nov; 139(11):1185-8.
    View in: PubMed
    Score: 0.003
  94. Latency period of thyroid neoplasia after radiation exposure. Ann Surg. 2004 Apr; 239(4):536-43.
    View in: PubMed
    Score: 0.003
  95. Intraoperative imprint cytologic evaluation of sentinel lymph nodes for lobular carcinoma of the breast. Ann Surg. 2004 Jan; 239(1):61-6.
    View in: PubMed
    Score: 0.003
  96. Enhanced scintigraphic protocol required for optimal preoperative localization before targeted minimally invasive parathyroidectomy. Clin Nucl Med. 2003 Dec; 28(12):955-60.
    View in: PubMed
    Score: 0.003
  97. Incidental thyroid carcinoma identified by positron emission tomography scanning obtained for metastatic evaluation. Am Surg. 2001 Jun; 67(6):582-4.
    View in: PubMed
    Score: 0.003
  98. Reoperative parathyroid surgery in the era of sestamibi scanning and intraoperative parathyroid hormone monitoring. Arch Surg. 1999 Jul; 134(7):699-704; discussion 704-5.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.